PRJNA542615
Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes
Most patients diagnosed with pancreatic adenocarcinoma survive less than 5-years, but a minor subset of patients survive longer. Utilizing 16S rRNA gene sequencing, we dissect the role of the tumor associated microbiota and the immune system in influencing long-term survival.